Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,971 | 153 | 99.3% |
| Education | $20.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $808.23 | 52 | $0 (2024) |
| ABBVIE INC. | $524.85 | 26 | $0 (2024) |
| Gilead Sciences, Inc. | $232.56 | 14 | $0 (2023) |
| Janssen Biotech, Inc. | $144.46 | 7 | $0 (2024) |
| Celgene Corporation | $138.05 | 6 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $131.26 | 3 | $0 (2017) |
| Novo Nordisk Inc | $124.99 | 1 | $0 (2022) |
| RedHill Biopharma Inc. | $84.38 | 5 | $0 (2021) |
| AIMMUNE THERAPEUTICS, INC. | $83.96 | 4 | $0 (2024) |
| Ardelyx, Inc. | $77.53 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $791.47 | 42 | ABBVIE INC. ($207.41) |
| 2023 | $308.86 | 16 | Celgene Corporation ($57.49) |
| 2022 | $280.53 | 8 | Novo Nordisk Inc ($124.99) |
| 2021 | $284.18 | 16 | EVOKE PHARMA, INC. ($71.55) |
| 2020 | $320.52 | 16 | AbbVie Inc. ($68.88) |
| 2019 | $358.84 | 24 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($248.24) |
| 2018 | $443.64 | 26 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($264.11) |
| 2017 | $203.13 | 6 | Valeant Pharmaceuticals North America LLC ($131.26) |
All Payment Transactions
154 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.51 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/13/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $35.73 | General |
| Category: LIVER DISEASE | ||||||
| 11/06/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: IMMUNOLOGY | ||||||
| 10/09/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.24 | General |
| Category: Gastroenterology | ||||||
| 10/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: LIVER DISEASE | ||||||
| 09/26/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $26.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $8.61 | General |
| Category: Gastroenterology | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: LIVER DISEASE | ||||||
| 09/11/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 09/07/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $2.41 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: VIROLOGY | ||||||
| 08/15/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.85 | General |
| Category: VIROLOGY | ||||||
| 07/24/2024 | PFIZER INC. | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 07/17/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | Ipsen Biopharmaceuticals, Inc | Bylvay (Drug), IQIRVO | Education | In-kind items and services | $20.00 | General |
| Category: Gastroenterology | ||||||
| 06/27/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $34.73 | General |
| Category: Immunology | ||||||
| 06/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: Gastroenterology | ||||||
| 06/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: Gastroenterology | ||||||
| 05/23/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.33 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,114 | 2,476 | $865,751 | $198,444 |
| 2022 | 16 | 1,096 | 2,664 | $745,937 | $192,407 |
| 2021 | 16 | 1,098 | 2,505 | $723,041 | $189,624 |
| 2020 | 16 | 1,093 | 2,618 | $749,799 | $195,773 |
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 346 | 1,598 | $395,522 | $105,162 | 26.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 297 | 347 | $142,299 | $37,656 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 135 | $53,557 | $14,233 | 26.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 95 | 101 | $117,357 | $9,516 | 8.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 92 | 110 | $30,632 | $7,977 | 26.0% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2023 | 24 | 25 | $16,084 | $4,274 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 32 | 32 | $16,674 | $4,236 | 25.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 34 | 34 | $11,984 | $2,995 | 25.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 14 | 14 | $19,996 | $2,930 | 14.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $27,224 | $2,824 | 10.4% |
| 44361 | Biopsy of small bowel (except ileum) using an endoscope | Facility | 2023 | 18 | 18 | $8,950 | $2,114 | 23.6% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 13 | 14 | $14,981 | $2,062 | 13.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $6,253 | $1,338 | 21.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 16 | 16 | $4,239 | $1,126 | 26.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 283 | 1,522 | $353,054 | $89,367 | 25.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 201 | 242 | $105,684 | $27,112 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 111 | 157 | $39,269 | $15,840 | 40.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 111 | 116 | $54,872 | $11,636 | 21.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 94 | 106 | $34,631 | $8,964 | 25.9% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 50 | 259 | $32,551 | $8,360 | 25.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 36 | 38 | $24,584 | $6,204 | 25.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 29 | 32 | $22,504 | $4,027 | 17.9% |
| 43246 | Insertion of stomach tube using a flexible endoscope | Facility | 2022 | 20 | 20 | $13,693 | $3,452 | 25.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 45 | $7,576 | $3,296 | 43.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 37 | $12,273 | $3,113 | 25.4% |
About Dr. Mayuri Gupta, MD
Dr. Mayuri Gupta, MD is a Internal Medicine healthcare provider based in Lighthouse Point, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/08/2007. The National Provider Identifier (NPI) number assigned to this provider is 1114075785.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mayuri Gupta, MD has received a total of $2,991 in payments from pharmaceutical and medical device companies, with $791.47 received in 2024. These payments were reported across 154 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,971).
As a Medicare-enrolled provider, Gupta has provided services to 4,401 Medicare beneficiaries, totaling 10,263 services with total Medicare billing of $776,248. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Lighthouse Point, FL
- Active Since 01/08/2007
- Last Updated 10/25/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1114075785
Products in Payments
- XIFAXAN (Drug) $749.27
- MAVYRET (Drug) $194.03
- STELARA (Biological) $144.46
- Rybelsus (Drug) $124.99
- ZEPOSIA (Drug) $102.09
- ZENPEP (Drug) $96.75
- IBSRELA (Drug) $77.53
- CREON (Drug) $76.63
- APRISO (Drug) $74.86
- GIMOTI (Drug) $71.55
- RESMETIROM (Drug) $70.44
- RINVOQ (Biological) $66.86
- LINZESS (Drug) $62.33
- DIFICID (Drug) $52.77
- Linzess (Drug) $50.36
- Talicia (Drug) $47.05
- Viekira (Drug) $46.50
- ENTYVIO (Biological) $40.68
- ACQUIRE (Device) $39.12
- VIBERZI (Drug) $38.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lighthouse Point
Dr. Vipin Gupta, Md, MD
Internal Medicine — Payments: $11,924
Dr. Amal Hanna, M.d, M.D
Internal Medicine — Payments: $2,917
Edward Winokur, Md, MD
Internal Medicine — Payments: $513.92
Dr. Christopher Deleo, M.d, M.D
Internal Medicine — Payments: $478.14
Helene Head, Md, MD
Internal Medicine
Dr. Arthur Bautista, Md, MD
Internal Medicine